Inherited Thromophilia and Thrombotic Risks in Inflammatory Bowel Disease During Activity and Remission
Observational · No treatment assigned · Sites not listed yet · Asmaa mohammed abdelaal abdelaal
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Inflammatory Bowel Diseases. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 to 75
- Any sex
Some of the main requirements, copied from the record:
- Age (18yrs - 65yrs) both sex
There are also 1 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 93 participants are expected to take part.
- Start date: 2024-11 (planned).
- Main results expected around 2026-12 (estimate from the record).
- No study sites are listed yet. Check the official record for contact details.
Main thing being measured
- Comparison between the number of IBD patients with tendency to thrombosis in cases of activity- (Baseline)
In the researchers’ words
Inherited thombopllia and thrombotic risks in inflammatory bowel Disease during activity and remission
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Inflammatory Bowel Diseases |
| Lead sponsor | Asmaa mohammed abdelaal abdelaal |
| Collaborators | Assiut University |
| Enrollment | 93 (estimated) |
| Start date | 2024-11 |
| Primary completion (est.) | 2026-12 |
| First posted | 2024-11-15 |
| Last updated | 2024-11-15 |
| Official title | Inherited Thrombophilia and Thrombotic Risks in Inflammatory Bowel Disease During Activity and Remission |
| ClinicalTrials.gov ID | NCT06691451 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * Age (18yrs - 65yrs) both sex Exclusion Criteria: * Presence of acquired cause (pregnancy, recent surgery, history of drug, History of malignant Disease, History of blood or blood product transfusion in last 4 weeks)
Locations (0)
No sites listed yet. The official record has contact information.
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.